Galecto Inc

GLTO.US
Healthcare · Biotechnology
Price N/A
USD · NASDAQ

Company Information

Company Name
Galecto Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US36322Q1076
CIK: 0001800315
CUSIP: 36322Q107
Currency: USD
Full Time Employees: 5
Phone: 45 70 70 52 10
Fiscal Year End: December
IPO Date: Oct 29, 2020
Description:

Damora Therapeutics, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases. It develops GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 and GB1211, an oral small molecule inhibitor of galectin-3 to treat multiple types of oncology and liver disease indications. The company was founded in 2011 and is headquartered in Copenhagen, Denmark.

Address:

Ole Maaloes Vej 3, Copenhagen, Denmark, 2200

People

Directors & Officers

Name Title Year Born
Ms. Lori C. Firmani Chief Financial Officer 1974
Mr. Garrett Winslow Esq. Senior VP, General Counsel & Corporate Secretary 1980
Mr. Sherwin Sattarzadeh Interim Principal Executive Officer & COO NA
Mr. Ulf J. Nilsson Ph.D. Co-Founder NA
Dr. Hakon Leffler M.D., Ph.D. Co-Founder NA
Prof. Tariq Sethi B.Sc., FRCP, M.A., M.D., Ph.D. Co-Founder NA
Dr. Becker Hewes M.D. Chief Medical Officer 1967

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Jan 02, 2026 Hans T Schambye N/A Sale 700.00 $21.38 $14.97K
Jan 02, 2026 Lori Firmani N/A Sale 135.00 $21.41 $2.89K
Jul 03, 2025 Hans T Schambye N/A Sale 735.00 $3.38 $2.48K
Jul 03, 2025 Lori Firmani N/A Sale 147.00 $3.39 $498.33

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
FMR Inc 9.05M Mar 31, 2026 14.70% $0.01 3,686.65%
Fairmount Funds Management LLC 8.71M Mar 31, 2026 14.16% $16.30 0.00%
venBio Select Advisor LLC 3.78M Mar 31, 2026 6.15% $0.96 0.00%
VR Adviser, LLC 3.60M Mar 31, 2026 5.85% $3.48 0.00%
FCPM III SERVICES BV 2.44M Mar 31, 2026 3.97% $8.75 0.00%
RA Capital Management, LLC 2.40M Mar 31, 2026 3.90% $0.66 0.00%
HHG PLC 2.36M Mar 31, 2026 3.84% $0.03 135,765.21%
Viking Global Investors LP 2.31M Mar 31, 2026 3.75% $0.17 0.00%
Bellevue Group AG 2.30M Mar 31, 2026 3.73% $1.42 0.00%
COMMODORE CAPITAL LP 1.94M Mar 31, 2026 3.15% $2.91 0.00%
Cormorant Asset Management, LLC 1.53M Mar 31, 2026 2.48% $1.98 0.00%
Balyasny Asset Management LLC 1.45M Mar 31, 2026 2.35% $0.05 0.00%
Perceptive Advisors LLC 1.22M Mar 31, 2026 1.99% $0.62 0.00%
Point72 Asset Management, L.P. 1.19M Mar 31, 2026 1.94% $0.04 995.15%
Wellington Management Company LLP 1.06M Mar 31, 2026 1.72% $0.01 0.00%
Siren, L.L.C. 900.00K Mar 31, 2026 1.46% $0.65 0.00%
BRAIDWELL LP 894.85K Mar 31, 2026 1.45% $0.77 0.00%
Vestal Point Capital LP 600.00K Mar 31, 2026 0.97% $0.43 0.00%
Blackstone Inc 503.52K Mar 31, 2026 0.82% $0.05 0.00%
Millennium Management LLC 471.65K Mar 31, 2026 0.77% $0.01 0.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Fidelity Growth Compy Commingled Pl S 2.45M 3.97% ▲ 0.15% Apr 30, 2026
2 Fidelity Growth Company Fund 1.76M 2.86% ▲ 0.08% Apr 30, 2026
3 Fidelity Small Cap Growth 834.04K 1.36% ▲ 0.00% Mar 31, 2026
4 Fidelity Growth Company K6 518.78K 0.84% ▼ 0.24% Apr 30, 2026
5 Fidelity Select Health Care 500.00K 0.81% ▲ 0.00% Apr 30, 2026
6 Fidelity Select Biotechnology 454.56K 0.74% ▲ 0.00% Apr 30, 2026
7 Fidelity Series Growth Company 436.54K 0.71% ▲ 0.09% Apr 30, 2026
8 Fidelity Small Cap Growth K6 410.18K 0.67% ▲ 0.00% Mar 31, 2026
9 Fidelity Stock Selector Small Cap 403.20K 0.66% ▲ 0.00% Mar 31, 2026
10 Fidelity Series Small Cap Opps 308.40K 0.50% ▲ 0.00% Mar 31, 2026

Financial Highlights

Market Cap: $1.73B
EBITDA: $-11.86M
Book Value: $5.02
Earnings/Share: $-12.11
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -43.54%
ROE (TTM): -109.49%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Valuation Metrics

Enterprise Value: $1.61B
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 60.24M
Shares Float: 1.05M
% Insiders: 146.40%
% Institutions: 796.10%
Short % Float: 0.46%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$0.00
Cost of Goods Sold
adjust
$-34.00K
Gross Profit
subtotal
$-34.00K
SG&A
adjust
$-9.69M
R&D
adjust
$-201.19M
Operating Income
subtotal
$-210.87M
Other / Non-Operating Items
adjust
$1.03M
Net Income
subtotal
$-209.84M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about GLTO.US!